| 
             
			
			 All six of the fish oil supplements the researchers tested contained 
			a specific fatty acid that's been found to reduce the effectiveness 
			of chemotherapy in mice, the researchers report in JAMA Oncology. 
			 
			People receiving chemotherapy should refrain from taking fish oil 
			supplements and discuss any supplement with their doctors, said Dr. 
			Emile Voest, the study’s lead author from the Netherlands Cancer 
			Institute in Amsterdam. 
			 
			“I’m always discussing it with my patients,” he said. “Please have 
			an open relationship with me and tell me what you’re taking.” 
			 
			He and his colleagues say omega-3 fatty acids are consumed by about 
			a fifth of Americans with cancer – usually through fish oil. Fish 
			oil is often sold in capsules for about $10 or $11 for 100 pills. 
			 
			The researchers had previously found that even a small amount of two 
			fatty acids reduced the effectiveness of chemotherapy in mice with 
			cancer. These fatty acids may ultimately enable cancer cells to 
			repair themselves faster after chemotherapy, Voest said. 
			
			  
			 
			 
			When his team looked for the two fatty acids in six fish oil 
			supplements, one was not detected but the fatty acid called 
			16:4(n-3) was ubiquitous. 
			 
			The researchers also surveyed 400 people receiving treatment for 
			cancer in November 2011. Of 118 people who returned the surveys, 35 
			percent reported using nutritional supplements and 11 percent 
			reported using omega-3 fatty acid supplements. 
			 
			In another part of the study, the researchers then had 30 volunteers 
			without cancer take 10 or 50 milliliters (mL) of the three fish oil 
			supplements. Levels of 16:4(n-3) peaked in their blood about four 
			hours after taking the 10 mL supplements; levels returned to normal 
			after about eight hours. Levels of the fatty acid remained elevated 
			longer among those taking 50 mL. 
			 
			Furthermore, when 20 volunteers ate mackerel or herring, levels of 
			16:4(n-3) in their blood went up. Eating salmon or tuna had little 
			or no effect, however. 
			 
			The researchers conclude that until more is known, people on 
			chemotherapy should avoid fish oil - and herring and mackerel - the 
			day before and after their treatments. 
			 
			They note that the Dutch Cancer Society and the Dutch National 
			Working Group for Oncologic Dieticians recommend that people 
			receiving chemotherapy avoid fish oil around the time of treatment. 
			
            [to top of second column]  | 
            
             
  
				
			“It’s an intriguing observation, which warrants further 
			investigation,” said Dr. Powel Brown, chairman of the Department of 
			Clinical Cancer Prevention at the University of Texas M.D. Anderson 
			Cancer Center in Houston. 
			 
			“In general, when giving chemotherapy, we discourage the use of 
			additional supplements,” said Brown, who wasn’t involved with the 
			study. “It’s very well known that some supplements affect the 
			metabolism of chemotherapy.” 
			 
			Voest said the study’s conclusions are a bit circumstantial, but it 
			would be very difficult to conduct a trial to confirm the findings. 
			For example, it would be unethical to randomly give patients fish 
			oil during chemotherapy to see if it makes their treatment less 
			effective. 
			People should be cautious about going overboard with avoiding all 
			omega-3 fatty acids, because they're an essential part of the diet 
			that the body can’t make on its own, said Stacy Kennedy, an expert 
			on oncology nutrition at the Dana-Farber Cancer Institute in Boston. 
			 
			Flaxseed, chia seeds and walnuts are also sources of omega-3 fatty 
			acids. 
			 
			“I think it’s important to have those detailed conversations with 
			your doctors and dieticians to weigh the risk and benefits of any 
			over-the-counter medication, supplements and powders,” said Kennedy, 
			who also wasn’t involved in the study. 
			 
			SOURCE: http://bit.ly/1ClqxXP JAMA 
			Oncology, online April 2, 2015. 
			[© 2015 Thomson Reuters. All rights 
				reserved.] Copyright 2015 Reuters. All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed. 
			
			  
			
			   |